- Home
- APLT vs ADV Comparison
APLT vs ADV Comparison
Compare APLT & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- ADV
- Stock Information
- Founded
- APLT 2016
- ADV 1987
- Country
- APLT United States
- ADV United States
- Employees
- APLT N/A
- ADV N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- ADV Business Services
- Sector
- APLT Health Care
- ADV Consumer Discretionary
- Exchange
- APLT Nasdaq
- ADV Nasdaq
- Market Cap
- APLT 42.5M
- ADV 415.1M
- IPO Year
- APLT 2019
- ADV N/A
- Fundamental
- Price
- APLT $0.33
- ADV $1.32
- Analyst Decision
- APLT Buy
- ADV Strong Buy
- Analyst Count
- APLT 7
- ADV 1
- Target Price
- APLT $6.10
- ADV $2.50
- AVG Volume (30 Days)
- APLT 2.1M
- ADV 739.4K
- Earning Date
- APLT 08-06-2025
- ADV 08-06-2025
- Dividend Yield
- APLT N/A
- ADV N/A
- EPS Growth
- APLT N/A
- ADV N/A
- EPS
- APLT N/A
- ADV N/A
- Revenue
- APLT $265,000.00
- ADV $3,526,704,000.00
- Revenue This Year
- APLT $1,768.13
- ADV N/A
- Revenue Next Year
- APLT $292.85
- ADV N/A
- P/E Ratio
- APLT N/A
- ADV N/A
- Revenue Growth
- APLT N/A
- ADV N/A
- 52 Week Low
- APLT $0.30
- ADV $1.04
- 52 Week High
- APLT $10.62
- ADV $4.16
- Technical
- Relative Strength Index (RSI)
- APLT 42.58
- ADV 46.61
- Support Level
- APLT $0.30
- ADV $1.28
- Resistance Level
- APLT $0.39
- ADV $1.70
- Average True Range (ATR)
- APLT 0.03
- ADV 0.14
- MACD
- APLT 0.00
- ADV -0.03
- Stochastic Oscillator
- APLT 21.64
- ADV 11.96
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.